SCHEMBL23725858

SCHEMBL23725858

COc1c(C(=O)O)cc(Cl)c2nc(C)ccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.50
HTT P42858 3/20 0.50
PKM P14618 1/20 0.50
KMT2A Q03164 5/20 0.48
MAPT P10636 1/20 0.44
PDE4A P27815 1/20 0.44
PDE4B Q07343 1/20 0.44
PDE4C Q08493 1/20 0.44
PDE4D Q08499 1/20 0.44
ALDH1A1 P00352 5/20 0.43
HSD17B10 Q99714 3/20 0.43
HPGD P15428 2/20 0.43
GAA P10253 1/20 0.43
POLB P06746 1/20 0.43
SORT1 Q99523 1/20 0.42
PPARA Q07869 1/20 0.41
MEN1 O00255 2/20 0.41
NOTUM Q6P988 1/20 0.40
LMNA P02545 1/20 0.39
TPMT P51580 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23725191 0.80 NOTUM (0.40) KDM4EHTTKMT2AMAPTALDH1A1
SCHEMBL23725371 0.79 HIF1A (0.48) KDM4EKMT2AMAPTPDE4APDE4B
SCHEMBL3901240 0.77 PPARA (0.49) KDM4EHTTPKMKMT2AMAPT
SCHEMBL7686855 0.77 MAPT (0.67) KDM4EHTTPKMKMT2AMAPT
SCHEMBL23725188 0.76 KDM4E (0.46) KDM4EHTTKMT2AALDH1A1HSD17B10
SCHEMBL23724854 0.76 POLB (0.54) KDM4EHTTPKMKMT2AMAPT
SCHEMBL8967049 0.74 ALDH1A1 (0.60) KDM4EHTTPKMKMT2AMAPT
SCHEMBL25096343 0.74 MAPT (0.50) KDM4EHTTPKMKMT2AMAPT
SCHEMBL3899046 0.72 PDE4B (0.58) KDM4EKMT2AMAPTPDE4APDE4B
SCHEMBL27859515 0.71 TPMT (0.53) KDM4EHTTPKMKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (US) 2023-05-11 US disclosed
EP-4100381-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2022-12-14 EP disclosed
WO-2021158481-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2021-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME HAVCR2, HMBS, VHL KDM4E 224/4885HTT 241/4885PKM 4140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.